Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs geared toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where remedy possibilities remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/nuvei-enters-japanese-market-via-paywiser-acquisition/